Corporate Banner
Satellite Banner
Technology Networks Header
Friday, July 25, 2014
Technology Networks
 
Register | Sign in
Home Page>News

  News Archive

First Forensic Governance Programme a Success
Monday, October 21, 2013
Participants from across Europe said the course gave them useful tools, insights and inspiration that will speed up the development of their organisations.

Life Tech's Forensic Kit Approved by FBI
Friday, October 11, 2013
Life Technologies GlobalFiler™ Express Kit has been approved by the FBI for use by laboratories generating DNA profiles for inclusion in the National DNA Index System CODIS Database.

Recent Advances in 2D and 3D in vitro Systems
Sunday, October 06, 2013
The possibilities and limitations of the most useful liver in vitro systems are summarized, including 3D culture techniques, co-cultures with non-parenchymal cells.

New Genetic Discovery Could Reduce the Guesswork in Drug Dosing
Friday, October 04, 2013
Findings likely to improve how patients are prescribed one in four clinically used drugs.

The Effect of Fatal Carbon Monoxide Poisoning on the Surface Charge of Blood Cells
Monday, September 30, 2013
This study can help in both the interpretation as well as understanding of the processes that take place on biological membrane surfaces after fatal CO poisoning.

GBI’s DNA Database Has Over 3,500 Confirmed Hits
Monday, September 30, 2013
The DNA Database at the Georgia Bureau of Investigation (GBI) crime lab or CODIS (Combined DNA Index System) has reached over 3,500 hits to unsolved cases.

DNA Fingerprinting for Soils Might Soon Help Catch Criminals
Monday, September 16, 2013
In certain criminal cases, soil, mud or vegetation on, or from, a vehicle or foot, clothing or implements may provide the clue that could point to a particular search location.

AB SCIEX Receives Frost & Sullivan Award
Thursday, September 12, 2013
AB SCIEX has been awarded the 2013 Global Market Share Leadership Award for Mass Spectrometry from Frost & Sullivan.

Stem Cell Therapeutics Advances CD47 Antagonist Program into Ind-Enabling Phase
Monday, September 09, 2013
Stem Cell Therapeutics Corp. announced that it has advanced its CD47 antagonist program into an Investigational New Drug (IND) enabling phase.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 163
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv